State Street Portfolio holdings
State Street Corporation, established in 1792 and headquartered in Boston, Massachusetts, is one of the oldest financial institutions in the United States and a major player in the global asset management and custody banking sectors. Primarily known for its custodial services, it safeguards assets for institutional investors, managing trillions of dollars through its State Street Global Advisors (SSGA) division, which is renowned for launching the first U.S. exchange-traded fund (ETF), the SPDR S&P 500 ETF (SPY), in 1993. The company provides a range of services including investment management, research, trading, and data analytics, catering mostly to institutional clients like pension funds, endowments, and mutual funds. With a focus on financial infrastructure and innovation, State Street has positioned itself as a key backbone in the global investment ecosystem.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.05B |
| 2 |
Apple
AAPL
|
+$2.71B |
| 3 |
Microsoft
MSFT
|
+$2.39B |
| 4 |
Parker-Hannifin
PH
|
+$2.39B |
| 5 |
Sherwin-Williams
SHW
|
+$2.25B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$1.44B |
| 2 |
MRO
Marathon Oil Corporation
MRO
|
+$967M |
| 3 |
CTLT
CATALENT, INC.
CTLT
|
+$451M |
| 4 |
Marathon Petroleum
MPC
|
+$267M |
| 5 |
Dow Inc
DOW
|
+$252M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.33% |
| 2 | Financials | 13.84% |
| 3 | Consumer Discretionary | 10.66% |
| 4 | Healthcare | 10.52% |
| 5 | Industrials | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ZBIO
3176
Zenas BioPharma
ZBIO
$1.98B
| $1.73M | ﹤0.01% |
+211,506
| New | +$3.3M |
|
|
STRS
3177
DELISTED
STRATUS PPTYS INC
STRS
| $1.73M | ﹤0.01% |
83,427
-126
| -0.2% | -$3.03K |
|
3178
Solid Biosciences
SLDB
$972M
| $1.73M | ﹤0.01% |
432,176
-9,364
| -2% | -$51.4K |
|
|
ADVM
3179
DELISTED
Adverum Biotechnologies
ADVM
| $1.73M | ﹤0.01% |
369,554
-62
| -0% | -$417 |
|
|
LNAI
3180
Lunai Bioworks
LNAI
$10.7M
| $1.73M | ﹤0.01% |
25,811
+9,263
| +56% | +$615K |
|
3181
NN Inc
NNBR
$302M
| $1.72M | ﹤0.01% |
525,708
+11,300
| +2% | +$43.1K |
|
3182
Brookfield Asset Management
BAM
$87.1B
| $1.69M | ﹤0.01% |
31,269
-2,149
| -6% | -$116K |
|
3183
Ares Capital
ARCC
$14.3B
| $1.68M | ﹤0.01% |
76,823
| – | – |
|
3184
Hamilton Beach Brands
HBB
$443M
| $1.68M | ﹤0.01% |
99,851
+1,509
| +2% | +$34.9K |
|
|
HUYA
3185
Huya Inc
HUYA
$547M
| $1.68M | ﹤0.01% |
546,078
-84,508
| -13% | -$300K |
|
|
MPX
3186
DELISTED
Marine Products Corp
MPX
| $1.67M | ﹤0.01% |
182,469
+3,511
| +2% | +$33.8K |
|
|
RGLS
3187
DELISTED
Regulus Therapeutics
RGLS
| $1.67M | ﹤0.01% |
1,056,411
+55,413
| +6% | +$85.1K |
|
3188
Tilly's
TLYS
$121M
| $1.66M | ﹤0.01% |
391,682
-8,129
| -2% | -$33.2K |
|
|
ARTV
3189
Artiva Biotherapeutics
ARTV
$564M
| $1.66M | ﹤0.01% |
164,783
+78,224
| +90% | +$940K |
|
3190
Neuropace
NPCE
$500M
| $1.66M | ﹤0.01% |
148,303
-7,187
| -5% | -$62.5K |
|
3191
Atossa Therapeutics
ATOS
$23.5M
| $1.66M | ﹤0.01% |
117,025
+1,544
| +1% | +$30.1K |
|
|
TWFG
3192
TWFG Inc
TWFG
$1.44B
| $1.66M | ﹤0.01% |
+53,765
| New | +$1.67M |
|
|
BLUE
3193
DELISTED
bluebird bio
BLUE
| $1.65M | ﹤0.01% |
197,921
+5,825
| +3% | +$50.9K |
|
3194
RELX
RELX
$60.2B
| $1.65M | ﹤0.01% |
36,340
-690
| -2% | -$32.3K |
|
3195
Geospace Technologies
GEOS
$67.9M
| $1.64M | ﹤0.01% |
163,397
-4,100
| -2% | -$45.6K |
|
3196
Escalade
ESCA
$284M
| $1.63M | ﹤0.01% |
113,856
-500
| -0.4% | -$7.22K |
|
3197
Commercial Vehicle Group
CVGI
$128M
| $1.61M | ﹤0.01% |
647,845
+2,965
| +0.5% | +$7.92K |
|
3198
Paysign
PAYS
$723M
| $1.6M | ﹤0.01% |
528,237
-1,800
| -0.3% | -$6.31K |
|
3199
Tenaya Therapeutics
TNYA
$171M
| $1.58M | ﹤0.01% |
1,103,092
+44,194
| +4% | +$99.1K |
|
3200
Harvard Bioscience
HBIO
$28.1M
| $1.57M | ﹤0.01% |
74,261
+2,522
| +4% | +$57.9K |
|
Similar funds
State Street's Q4 2024 Portfolio in Review
As of Q4 2024, State Street held 4,383 positions worth $2.53T, up 3.1% from $2.46T the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Trading was light in Q4 2024: portfolio turnover was 4.2%. State Street opened 100 new positions and exited 86, leaving the 4,383-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 28% a quarter earlier, followed by Financials and Consumer Discretionary.
- State Street's largest Q4 2024 buy was State Street Consumer Discretionary Select Sector SPDR ETF: 1,701,144 shares worth $191M.
- State Street added most to NVIDIA in Q4 2024, an estimated $3.05B increase.
- State Street's biggest Q4 2024 reduction was Chevron, cutting an estimated $1.44B.
- State Street fully exited Marathon Oil Corporation in Q4 2024, selling an estimated $967M.
- State Street's ten largest holdings make up 29% of its $2.53T portfolio in Q4 2024.
- State Street opened 100 new positions and closed 86 in Q4 2024.
- State Street's portfolio value rose 3.1% quarter-over-quarter to $2.53T.
Based on State Street's 13F filing for Q4 2024, filed 14 Feb 2025.